A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies

NCT06645886 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Malignancies
Adult

Interventions

DRUG: KQB198
DRUG: Dasatinib

Sponsor

Kumquat Biosciences Inc.